Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
MORE FILTERS
Scandpower excels through licence sales. Higher sick leave in Decommissioning. Minor revisions with '24e EBIT down 1%.
3 of 4 divisions showed progress in Q3. Scandpower was the outlier with no licence sales. '24e EBIT up 2%.
Decommissioning and Scandpower excel but are overshadowed by delays within F&MT. '23e-'25e EBIT revised down 11-2%.
Production stop in F&MT affects Q1. Decommissioning a bright spot. Report in line with ABGSCe when adjusted for F&MT.
Save your current filters as a new Interest
Would you like to receive real-time email alerts when a new report is published under this interest?
These search results will show up under 'Saved searches' in the left panel
Would you like to receive real-time email when a new report matches this search?
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.